LI Ji, LI Xiang, HU Xiaoyang, et al. Research progress of regulation of miRNA on myocardial ischemia reperfusion injury by traditional Chinese medicine. [J]. Shanghai Journal of Traditional Chinese Medicine 54(3):97-100(2020)
DOI:
LI Ji, LI Xiang, HU Xiaoyang, et al. Research progress of regulation of miRNA on myocardial ischemia reperfusion injury by traditional Chinese medicine. [J]. Shanghai Journal of Traditional Chinese Medicine 54(3):97-100(2020) DOI: 10.16305/j.1007-1334.2020.03.025.
Research progress of regulation of miRNA on myocardial ischemia reperfusion injury by traditional Chinese medicine
This paper reviews the latest research progress in the treatment of myocardial ischemia reperfusion injury(MIRI)by regulating micro ribonucleic acid(miRNA)as a target with traditional Chinese medicine monomer(ginsenoside 1, apigenin, salvianolic acid B, luteolin), compound prescription(Yiqi Huoxue compound, Tongxinluo)and acupuncture[electroacupuncture pretreatment, needling neiguan(PC6) point by electroacupuncture, needling neiguan(PC6) point in both sides by electroacupuncture in vivo and microcurrent pretreatment in vitro], which provides an entry point for traditional Chinese medicine treatment of myocardial ischemia reperfusion injury and related prognosis intervention.
关键词
心肌缺血再灌注损伤miRNA中医药疗法综述
Keywords
myocardial ischemia reperfusion injurymiRNAtraditional Chinese medicine therapyreview